PHK
EW icon

Point72 Hong Kong’s Edwards Lifesciences EW Stock Holding History

Point72 Hong Kong’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,300
Closed -$190K – 607
2022
Q3 		$190K Buy
+2,300
New +$221K 0.01% 1059
2021
Q4 		– Sell
-6,300
Closed -$713K – 2036
2021
Q3 		$713K Buy
6,300
+4,300
+215% +$491K 0.02% 841
2021
Q2 		$207K Buy
+2,000
New +$189K 0.01% 1145

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Point72 Hong Kong's EW Position: Q3 2025 in Review

Point72 Hong Kong sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 62,178 shares — an estimated $4.86M sold.

Point72 Hong Kong first reported a position in EW in Q4 2014 and held it in 24 quarters. The position peaked at $4.86M in Q2 2025. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Point72 Hong Kong reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 62,178 Edwards Lifesciences shares in Q3 2025, an estimated $4.86M.
  • Point72 Hong Kong first reported a position in Edwards Lifesciences in Q4 2014 and held it in 24 quarters.
  • Point72 Hong Kong's Edwards Lifesciences position peaked at $4.86M in Q2 2025.
  • 1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.